NeXstar regulatory update

NeXstar Pharmaceuticals Inc. (NXTR) The FDA's Oncology Drugs Advisory Committee will review on June 8-9 the Denver company's DaunoXome to treat Kaposi's sarcoma (KS). An amended NDA was filed in Janu...